Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...

Researchers based in Sweden have developed a metabolism-based model of mammalian cell types commonly used in antibody production. The team, led by Veronique Chotteau, PhD, a professor at KTH Royal ...

Join Dr. Mariah Pierce, Technical Account Manager at Sino Biological, as she introduces Sino Biological's cutting-edge, high-throughput, cell-free expression platform. This platform facilitates the ...